Quoin Pharmaceuticals Ltd ADR (QNRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,963 | -6,651 | -4,301 | -2,327 | -8,687 |
| Depreciation Amortization | 100 | 75 | 50 | 25 | 104 |
| Accounts payable and accrued liabilities | 276 | -108 | 371 | 643 | 54 |
| Other Working Capital | -2 | 209 | 311 | 659 | 95 |
| Other Operating Activity | 731 | 854 | 127 | -433 | 569 |
| Operating Cash Flow | $-7,857 | $-5,621 | $-3,442 | $-1,434 | $-7,864 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | 8,339 | N/A | N/A |
| Purchase Of Investment | -17,254 | -11,256 | -9,650 | -9,650 | -18,091 |
| Sale Of Investment | 15,366 | 12,546 | N/A | 5,184 | 20,279 |
| Investing Cash Flow | $-1,888 | $1,290 | $-1,311 | $-4,466 | $2,188 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 11,568 | 5,496 | 5,496 | 5,483 | 5,849 |
| Other Financing Activity | -600 | -450 | -300 | -150 | -633 |
| Financing Cash Flow | $10,968 | $5,046 | $5,196 | $5,333 | $5,217 |
| Beginning Cash Position | 2,401 | 2,401 | 2,401 | 2,401 | 2,861 |
| End Cash Position | 3,623 | 3,117 | 2,845 | 1,834 | 2,401 |
| Net Cash Flow | $1,222 | $716 | $444 | $-568 | $-459 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,857 | -5,621 | -3,442 | -1,434 | -7,864 |
| Free Cash Flow | -7,857 | -5,621 | -3,442 | -1,434 | -7,864 |